Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly J Yu

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|July 3, 2020
Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in TaiwanMei-Hsuan Lee, Yu-Han Huang, Anna E Coghill, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 29, 2014
Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in TaiwanAnna E Coghill, Wan-Lun Hsu, Ruth M Pfeiffer, et al.
Infectious Agents and Cancer|March 12, 2026
Assessing T-cell responses to Epstein-Barr virus in individuals at risk for nasopharyngeal carcinomaWan-Lun Hsu, Chieh-Ju Lee, Anna E Coghill, et al.
Journal of Medical Virology|January 3, 2013
Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinomaCindy Chang, Jaap Middeldorp, Kelly J Yu, et al.
International Journal of Cancer|June 1, 2024
Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex familiesWan-Lun Hsu, Jun Tao, Sheng Fu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 10, 2025
Real-world evidence regarding cancer, mortality, and graft failure risk with de novo belatacept use among kidney transplant recipients in the United StatesShyfuddin Ahmed, Ruth M Pfeiffer, Karena Volesky-Avellaneda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC familiesKelly J Yu, Wan-Lun Hsu, Ruth M Pfeiffer, et al.
Human Immunology|August 18, 2009
Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in TaiwanKelly J Yu, Xiaojiang Gao, Chien-Jen Chen, et al.
Journal of Clinical Microbiology|February 28, 2020
Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex SerologyJulia Simon, Zhiwei Liu, Nicole Brenner, et al.
Cancer Research|December 4, 2020
Patterns of Human Leukocyte Antigen Class I and Class II Associations and CancerZhiwei Liu, Andriy Derkach, Kelly J Yu, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|July 3, 2020
Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in TaiwanMei-Hsuan Lee, Yu-Han Huang, Anna E Coghill, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 29, 2014
Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in TaiwanAnna E Coghill, Wan-Lun Hsu, Ruth M Pfeiffer, et al.
Infectious Agents and Cancer|March 12, 2026
Assessing T-cell responses to Epstein-Barr virus in individuals at risk for nasopharyngeal carcinomaWan-Lun Hsu, Chieh-Ju Lee, Anna E Coghill, et al.
Journal of Medical Virology|January 3, 2013
Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinomaCindy Chang, Jaap Middeldorp, Kelly J Yu, et al.
International Journal of Cancer|June 1, 2024
Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex familiesWan-Lun Hsu, Jun Tao, Sheng Fu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 10, 2025
Real-world evidence regarding cancer, mortality, and graft failure risk with de novo belatacept use among kidney transplant recipients in the United StatesShyfuddin Ahmed, Ruth M Pfeiffer, Karena Volesky-Avellaneda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC familiesKelly J Yu, Wan-Lun Hsu, Ruth M Pfeiffer, et al.
Human Immunology|August 18, 2009
Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in TaiwanKelly J Yu, Xiaojiang Gao, Chien-Jen Chen, et al.
Journal of Clinical Microbiology|February 28, 2020
Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex SerologyJulia Simon, Zhiwei Liu, Nicole Brenner, et al.
Cancer Research|December 4, 2020
Patterns of Human Leukocyte Antigen Class I and Class II Associations and CancerZhiwei Liu, Andriy Derkach, Kelly J Yu, et al.
Pageof 8